8 October 2020
Kromek Group plc
("Kromek" or the "Group")
Notice of AGM and Publication of Annual Report
Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, gives notice that its Annual General Meeting ("AGM") will be held at 10.30am on 31 October 2020 at Kromek Group plc, North East Technology Park (NETPark), Thomas Wright Way, Sedgefield, County Durham TS21 3FD.
The Board recognises that the AGM represents an important opportunity to engage with shareholders, and provides a forum for shareholders to ask questions of, and speak directly with, the Board. However, in light of current social distancing measures, and following the local restrictions imposed by the Government in the North East of England, the AGM this year will be run as a closed meeting and shareholders will not be able to attend. The Group will make arrangements to ensure that the AGM is quorate and the format of the AGM will be purely functional. The Board has taken this decision in the interests of the health and wellbeing of the Group's people, shareholders and community, which is of foremost importance. Shareholders are therefore strongly encouraged to submit a proxy vote in advance of the AGM.
The notice of AGM and form of proxy, along with the Group's annual report and accounts for the year ended 30 April 2020, have been posted to shareholders and are available from the Group's website: www.kromek.com.
For further information, please contact:
Kromek Group plc |
|
Arnab Basu, CEO Derek Bulmer, CFO
|
+44 (0)1740 626 060 |
Cenkos Securities plc (Nominated Adviser and Broker) |
|
Max Hartley (NOMAD) Julian Morse (Sales)
|
+44 (0)20 7397 8900 |
Luther Pendragon (PR) |
|
Harry Chathli Claire Norbury Alexis Gore Joe Quinlan |
+44 (0)20 7618 9100 |
About Kromek Group plc
Kromek Group plc is a technology group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.
The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.
The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").
The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.
Currently, the Group has over one hundred full-time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and
https://twitter.com/kromekgroup.